Strengthening accrual to cancer clinical trials

被引：5
|
作者：
Trimble, Edward L. [1 ]
Denicoff, Andrea M. [1 ]
Abrams, Jeffrey S. [1 ]
机构：
[1] NCI, Canc Therapy Evaluat Program, Div Canc Treatment & Diag, NIH, Bethesda, MD 20892 USA
来源：
GYNECOLOGIC ONCOLOGY | 2010年 / 116卷 / 03期
关键词：
BARRIERS; IMPACT;
D O I：
10.1016/j.ygyno.2010.01.015
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：291 / 292
页数：2
相关论文
共 50 条
  • [21] Patient Enrollment per Month (Accrual) in Clinical Trials Leading to the FDA Approval of New Cancer Drugs
    Michaeli, Daniel Tobias
    Michaeli, Thomas
    Albers, Sebastian
    Michaeli, Julia Caroline
    TARGETED ONCOLOGY, 2024, 19 (05) : 797 - 809
  • [22] Increasing Accrual in Cancer Clinical Trials With a Focus on Minority Enrollment The William Beaumont Hospital Community Clinical Oncology Program Experience
    Vicini, Frank
    Nancarrow-Tull, Joyce
    Shah, Chirag
    Chmielewski, Gary
    Fakhouri, Monty
    Sitarek, Stacey A.
    Feczko, Claire T.
    Brzozowski, Carol
    Felten, David L.
    CANCER, 2011, 117 (20) : 4764 - 4771
  • [23] Challenges to accrual predictions to phase III cancer clinical trials: a survey of study chairs and lead statisticians of 248 NCI-sponsored trials
    Schroen, Anneke T.
    Petroni, Gina R.
    Wang, Hongkun
    Thielen, Monika J.
    Sargent, Daniel
    Benedetti, Jacqueline K.
    Cronin, Walter M.
    Wickerham, Donald L.
    Wang, Xiaofei F.
    Gray, Robert
    Cohn, Wendy F.
    Slingluff, Craig L., Jr.
    Djulbegovic, Benjamin
    CLINICAL TRIALS, 2011, 8 (05) : 591 - 600
  • [24] Overview of EMPaCT and Fundamental Issues Affecting Minority Participation in Cancer Clinical Trials: Enhancing Minority Participation in Clinical Trials ( EMPaCT): Laying the Groundwork for Improving Minority Clinical Trial Accrual
    Vickers, Selwyn M.
    Fouad, Mona N.
    CANCER, 2014, 120 : 1087 - 1090
  • [25] Improving the accrual of racial and ethnic minority patients in clinical trials: Time to raise the stakes
    Ibraheem, Abiola
    Polite, Blase
    CANCER, 2017, 123 (24) : 4752 - 4756
  • [26] Understanding the Barriers to Pediatric Oncologist Engagement and Accrual to Clinical Trials in National Cancer Institute-Designated Community Oncology Research Programs
    Dickens, David S.
    Roth, Michael E.
    Pollock, Brad H.
    Langevin, Anne-Marie
    JCO ONCOLOGY PRACTICE, 2020, 16 (10) : 677 - +
  • [27] Clinicians' attitudes towards clinical trials of cancer therapy
    Ford, E.
    Jenkins, V.
    Fallowfield, L.
    Stuart, N.
    Farewell, D.
    Farewell, V.
    BRITISH JOURNAL OF CANCER, 2011, 104 (10) : 1535 - 1543
  • [28] Recognizing the Financial Burden of Cancer Patients in Clinical Trials
    Nipp, Ryan D.
    Powell, Elizabeth
    Chabner, Bruce
    Moy, Beverly
    ONCOLOGIST, 2015, 20 (06) : 572 - 575
  • [29] Strengthening clinical cancer research in the United Kingdom
    Stead, M.
    Cameron, D.
    Lester, N.
    Parmar, M.
    Haward, R.
    Kaplan, R.
    Maughan, T.
    Wilson, R.
    Campbell, H.
    Hamilton, R.
    Stewart, D.
    O'Toole, L.
    Kerr, D.
    Potts, V.
    Moser, R.
    Darbyshire, J.
    Selby, P.
    BRITISH JOURNAL OF CANCER, 2011, 104 (10) : 1529 - 1534
  • [30] Institutional Clinical Trial Accrual Volume and Survival of Patients With Head and Neck Cancer
    Wuthrick, Evan J.
    Zhang, Qiang
    Machtay, Mitchell
    Rosenthal, David I.
    Nguyen-Tan, Phuc Felix
    Fortin, Andre
    Silverman, Craig L.
    Raben, Adam
    Kim, Harold E.
    Horwitz, Eric M.
    Read, Nancy E.
    Harris, Jonathan
    Wu, Qian
    Quynh-Thu Le
    Gillison, Maura L.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (02) : 156 - U56
12345